Effect of thyroid function on COPD exacerbation frequency: A preliminary study

Multidisciplinary Respiratory Medicine

Volumn 8, Issue 10, 2013, Pages

  Ulasli, Sevinc Sarinc ^a   Bozbas, Serife Savas ^b   Ozen, Zeynep Erayman ^b   Ozyurek, Berna Akinci ^c   Ulubay, Gaye ^b  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

Author keywords

COPD; Exacerbation frequency; Hypothyroidism; Quality of life

Indexed keywords

IODINE; THYROTROPIN;

ADULT; AGED; ARTICLE; BREATHING MUSCLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FREE LIOTHYRONINE INDEX; FREQUENCY ANALYSIS; HUMAN; HYPERINFLATION; HYPOTHYROIDISM; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MAXIMAL EXPIRATORY PRESSURE; MAXIMAL INSPIRATORY PRESSURE; MENTAL HEALTH; MUSCLE ATROPHY; NEUROMUSCULAR DISEASE; PROSPECTIVE STUDY; QUALITY OF LIFE; RESPIRATORY TRACT PARAMETERS; SHORT FORM 36; THYROID FUNCTION; THYROID FUNCTION TEST;

EID: 84885810132     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-8-64     Document Type: Article

References (32)

1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: (GOLD, updated 2013). Available at: http://www.goldcopd.org.
2. Fumagalli G, Fabiani F, Forte S, Napolitano M, Marinelli P, Palange P, Pentassuglia A, Carlone S, Sanguinetti CM: INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units. Multidiscip Resp Med 2013, 8:28.
3. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, vanEmpel VP, Bruijnzeel PL, Rutten EP, Roodt J, Wouters EF, Franssen FM: Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013, 187(7):728-735.
4. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG: Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 186(10):982-988.
5. Verleden GM, Demedts MG, Westhovens R, Thomeer M: Pulmonary manifestations of systemic diseases. EurRespir Monogr 2006, 34:234-252.
6. Zwillich CW, Pierson DJ, Hofeldt FD, Lufkin EG, Weil JV: Ventilatory control in myxedema and hypothyroidism. N Engl J Med 1975, 292:662-665.
7. Saaresranta T, Polo O: Hormones and breathing. Chest 2002, 122:2165-2182.
8. Siafakas NM, Salesiotou V, Filaditaki V, Tzanakis N, Thalassinos N, Bouros D: Respiratory muscle strength in hypothyroidism. Chest 1992, 102:189-194.
9. Datta D, Scalise P: Hypothyroidism and failure to wean in patients receiving prolonged mechanical ventilation at a regional weaning center. Chest 2004, 126:1307-1312.
10. Laghi F, Tobin MJ: Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003, 168:10-48.
11. Creutzberg EC, Casaburi R: Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J 2003, 22:76-80.
12. Gow SM, Seth J, Beckett GJ, Douglas G: Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive pulmonary disease. Thorax 1987, 42:520-525.
13. Dimopoulou I, Ilias I, Mastorakos G, Mantzos E, Roussos C, Koutras DA: Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism 2001, 50:1397-1401.
14. Soyyigit S, Curgunlu A, Tufekci IB, Tutluoglu B: The incidence of sick euthyroid syndrome in acute exacerbation of COPD. Solunum 2004, 6:14-17.
15. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-968.
16. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338.
17. American Thoracic Society/European Respiratory Society: ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002, 166(4):518-624.
18. Dimitriadis Z, Kapreli E, Konstantinidou I, Oldham J, Strimpakos N: Test/ retest reliability of maximum mouth pressure measurements with the MicroRPM in healthy volunteers. Respir Care 2011, 56(6):776-782.
19. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto L, Antó JM: Chronic obstructive pulmonary disease stage and health- related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997, 127:1072-1079.
20. Ulubay G, Ulasli SS, Akinci B, Gorek A, Akcay S: Assessment of relation among emotional status, pulmonary function test, exercise performance, and quality of life in patients with COPD. Tuberk Toraks 2009, 57(2):169-176.
21. Ware JE, Sherbourne CD: The MOS 36-item Short- Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
22. Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, Pinet C, Jebrak G, Brinchault G, Court-Fortune I, Paillasseur JL, Roche N, INITIATIVES BPCO Scientific Committee: Impact of comorbidities on COPD-specific healthrelated quality of life. Respir Med 2013, 107(2):233-241.
23. Pickard AS, Yang Y, Lee TA: Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes 2011, 18(9):26.
24. Akinci AC, Pinar R, Demir T: The relation of the subjective dyspnoea perception with objective dyspnoea indicators, quality of life and functional capacity in patients with COPD. J Clin Nurs 2013, 22(7-8):969-976.
25. Soyyiǧit S, Erk M, Güler N, Kilinç G: The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease. Tuberk Toraks 2006, 54(3):259-266.
26. Ståhl E, Lindberg A, Jansson SA, Rönmark E, Svensson K, Andersson F, Löfdahl CG, Lundbäck B: Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 2005, 3:56.
27. Klaver EI, van Loon HC, Stienstra R, Links TP, Keers JC, Kema IP, Muller Kobold AC, Van der Klauw MM, Wolffenbuttel BH: Thyroid hormone status and health-related quality of life in the lifeLines cohort study. Thyroid 2013, 23:1066-1073. doi:10.1089/thy.2013.0017.
28. Terzano C, Ceccarelli D, Conti V, Graziani E, Ricci A, Petroianni A: Maximal respiratory static pressures in patients with different stages of COPD severity. Respir Res 2008, 9:8.
29. Rochester DF: Malnutrition and the respiratory muscles. Clin Chest Med 1986, 7:91-99.
30. Openbrier DR, Irwin MM, Rogers RM, Gottlieb GP, Dauber JH, Van Thiel DH, Pennock BE: Nutritional status and lung function in patients with emphysema and chronic bronchitis. Chest 1983, 83:17-22.
31. Decramer M, Stas KJ: Corticosteroids induced myopathy involving respiratory muscles in patient with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 1992, 146:800-802.
32. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57(10):847-852.